Edit |   |
---|---|
Antigenic Specificity | CD262, Human (Tigatuzumab biosimilar) |
Clone | Tigatuzumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | IF, IP, Neut, FuncS, ELISA, FCM |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD262 Recombinant Antibody (Tigatuzumab). Tigatuzumab (CS-1008) is a monoclonal antibod for the treatment of cancer. As of October 2009, a clinical trial for the treatment of pancreatic cancer, Phase II trials for colorectal cancer, non-small cell lung cancer, and ovarian cancer have been completed. |
Immunogen | n/a |
Other Names | Anti-CD262 Recombinant Antibody, Research Grade Tigatuzumab, Anti-Human CD262 Recombinant Antibody(Tigatuzumab), CS-1008, TRA-8, Antibody Drug Analogues, Monoclonal Antibody, YR1151, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 918127-53-4 |
Catalog # | YR1151 |
Price | please inquire |
Order / More Info | CD262, Human (Tigatuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |